Popular search terms:
Search Results
63 results found-
As is with other influenza vaccines, children who have received the appropriate course of FLUAD® Pediatric or another seasonal influenza vaccine are considered to be primed.
https://www.cslseqirus.ca/-/media/seqirus-canada/docs-en/fluad_en-clean-pm_asu-2024-2025_watermark.pdf -
9.2 Drug Interactions Overview No interaction studies have been performed on interaction between influenza vaccines in general and other vaccines or medications.
https://www.cslseqirus.ca/-/media/seqirus-canada/docs-en/afluria-tetra_en-clean-pm_asu-2024-2025_watermark.pdf -
Therefore, inactivated influenza vaccines are standardized to contain the hemagglutinin of influenza virus strains representing the influenza viruses likely to circulate in Canada in the upcoming winter on the basis of the recommendations from the World Health Organization (WHO) and the National Advisory Committee on Immunization (NACI).
https://www.cslseqirus.ca/-/media/seqirus-canada/docs-en/flucelvax-quad_en-clean-pm_asu-2024-2025_watermark.pdf -
CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government’s outbreak and preparedness response.
https://www.cslseqirus.ca/news/csl-seqirus-announces-us-government-award-in-response-to-avian-influenza -
Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons
https://www.cslseqirus.ca/news/recently-published-real-world-evidence-study -
CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.cslseqirus.ca/our-company -
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.cslseqirus.ca/news/news-archives -
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.cslseqirus.ca/ -
CSL Seqirus Commends the National Advisory Committee on Immunization for Preferential Recommendation of Enhanced Influenza Vaccines for Adults 65 and Older
https://www.cslseqirus.ca/news/seqirus-commends-naci-for-preferential-influenza-for-adults-65-and-older